Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Diabetes Devices Market

  • MAR2979137
  • 224 Pages
  • October 2018
  • Pharmaceuticals
Download Sample    Get Discount   
 
The Global Diabetes Devices Market was valued at $18.5 billion in 2015 and is expected to grow at a CAGR of 5.93% to reach $30.25 billion by 2021. Glucose monitoring devices will be the largest growing category in the market with a CAGR of 6.02 % followed by insulin delivery devices forecasted to grow at a CAGR of 5.59 %. Diabetes is a metabolic disorder in which the pancreas ability to produce or use insulin is affected and hence blood glucose levels rises than the normal level of glucose. Diabetes devices are used for monitoring and management of the level of glucose in a diabetic patient's body. These devices also facilitate the delivery of insulin in the patient's body.

Market Dynamics

The Diabetes Market is driven by large diabetic patient pool caused by rapid urbanization and sedentary lifestyle. In addition, factors such as more R&D in diabetes diagnosis, technological advancements in the field of diabetes devices and a demand for faster and safer diagnosis & treatment of diabetes are adding to growth. The growing demand for minimally or non-invasive products is expected to propel the market growth further.

There are certain restraints in the market such as high cost associated with the diagnosis and treatment, irregular reimbursement and patent expiry. In addition, certain devices don't give an exact figure but a range in which a certain parameter may lie, for example, blood glucose monitoring devices give a range about the blood glucose level of a patient.

Market Segmentation

The market is segmented into

Glucose Monitoring Devices Market

--> Blood glucose meters

--> Testing strips

--> Blood glucose testing strips

--> Continuous glucose monitoring device

--> Lancets

Insulin Delivery Devices Market Glucose

--> Insulin syringes

--> Insulin pumps

--> Insulin pens

--> Insulin injectors

Geographic Analysis

North America has the largest market share of around 32% in 2015 and is expected to grow at a CAGR of 5.9%. The US is the major revenue pocket in this region. In 2015, Europe was the second largest market followed by Asia-Pacific. Asia-Pacific will be the fastest growing segment in this market especially countries like China and India owing to the high prevalence of diabetes, growing disposable income, rising awareness regarding these devices among others.

Key Companies

The key players profiled in this market are Abbott Laboratories, Dexcom Inc., ACON Laboratories Inc., Becton, Dickinson and Company, Johnson & Johnson, Dexcom Inc., F. Hoffmann-La Roche Ltd, Medtronic plc and Terumo Corporation.

The report contains comprehensive analysis on:

--> Diabetes Devices Market Segments

--> Diabetes Devices Market Drivers, Restraints and Opportunities

--> Diabetes Devices Market Size & Forecast 2016 to 2022

--> Supply & Demand Value Chain

--> Diabetes Devices Market Current Trends

--> Competition & Major Companies

--> Technology and R&D Status

--> Porters Five Force Analysis

--> Strategic and Critical Success Factor Analysis of Key Players

Regional analysis Diabetes Devices Market includes

--> North America

>> US and Canada

--> Latin America

>> Mexico, Brazil, Argentina and Rest of Latin America

--> Western Europe

>> EU5 (Germany, France, Italy, Spain, U.K.)

>> Nordic Countries (Denmark, Finland, Norway, and Sweden)

>> Benelux (Belgium, The Netherlands, and Luxembourg)

>> Rest of Western Europe

--> Eastern Europe

>> Russia

>> Poland

>> Rest of Eastern Europe

--> Asia Pacific

>> China

>> India

>> Japan

>> Australia and New Zealand

>> Rest of Asia Pacific

--> Middle East and Africa

>> GCC countries (Saudi Arabia, Oman, Qatar, Bahrain, UAE and Kuwait)

>> South Africa

>> North Africa

>> Rest of Middle East and Africa

This report is an elaborate aggregation of primary inputs from industry experts and participants across the supply chain. It provides in-depth market segmentation that is derived from extensive product mapping exercises, macro-economic factors and other qualitative and quantitative insights. The impact of all such factors are delivered across multiple market segments and geographies.

Report Highlights::

--> Detailed Historical Overview (Market Origins, Product Launch Timeline, etc.)

--> Consumer and Pricing Analysis

--> Market dynamics of the industry

--> In-depth Market Segmentation

--> Historical and Projected Market Sizing in terms of volume and value

--> Recent market trends and Impact Factors

--> R&D Status and Technology Overview

--> Extensive Industry Structure Coverage

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390